General Biol

Shanghai-based contract research, development, and manufacturing organization (CRDMO) Ribobay Pharma has announced plans to commence offering GMP-level CRDMO services for oligonucleotide manufacturing in the near future. In collaboration with its spin-off company, General Biol (Anhui) Co., Ltd, the companies aim to provide access to Cytiva’s FlexFactory platform for oligo manufacturing.…